524322 KABRADG

Kabra Drugs Share Price

 

 

Start SIP in KABRADG

Start SIP

Performance

  • Low
  • ₹27
  • High
  • ₹29
  • 52 Week Low
  • ₹10
  • 52 Week High
  • ₹33
  • Open Price₹28
  • Previous Close₹28
  • Volume89,880
  • 50 DMA₹26.83
  • 100 DMA₹23.73
  • 200 DMA₹19.18

Investment Returns

  • Over 1 Month + 0.59%
  • Over 3 Month + 50.94%
  • Over 6 Month + 45.67%
  • Over 1 Year + 185.98%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 57.1
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 68
  • P/B Ratio
  • 2.6
  • Average True Range
  • 1.74
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.81
  • RSI
  • 50.44
  • MFI
  • 65.52

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹28.77
+ 0.78 (2.79%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹28.79
  • 50 Day
  • ₹26.83
  • 100 Day
  • ₹23.73
  • 200 Day
  • ₹19.18

Resistance and Support

27.97 Pivot Speed
  • R3 31.54
  • R2 30.17
  • R1 29.34
  • S1 27.14
  • S2 25.77
  • S3 24.94

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results
2025-10-08 Others Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.
2025-09-02 Others Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.
2025-08-14 Quarterly Results

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
95%
5%

About Kabra Drugs

  • NSE Symbol
  • KABRADG
  • BSE Symbol
  • 524322
  • Managing Director
  • Mr. N Aravind
  • ISIN
  • INE323K01017

Similar Stocks to Kabra Drugs

Kabra Drugs FAQs

Kabra Drugs share price is ₹28 As on 13 January, 2026 | 03:31

The Market Cap of Kabra Drugs is ₹68.2 Cr As on 13 January, 2026 | 03:31

The P/E ratio of Kabra Drugs is 57.1 As on 13 January, 2026 | 03:31

The PB ratio of Kabra Drugs is 2.6 As on 13 January, 2026 | 03:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23